EP0245700A2

Alkylcarbamylmethylated aminotriazine crosslinking agents and curable compositions containing the same.

Abstract

Novel alkylcarbamylmethyl aminotriazines self-cure and also function as crosslinkers for compounds containing active hydrogen groups. When the active hydrogen-containing compounds are hydroxylated polymer, coatings are provided with exceptional resistance to detergent and salt-spray exposure and improved abrasion resistance. The novel aminotriazines also can be combined with fillers as binders which when cured provide shaped articles of manufacture, such as insulation and foundry core molds.

EP0245700A2, drawing sheet 1
Sheet 1 of 32

Term

Term ended

Projected expiry passed 29 April 2007, 19.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

10 claims: 10 independent, 0 dependent

  1. 1
    A triazine compound selected from (i) a triaminotriazine compound of the formula C3N6(CH2OR)6-x(CH2NHCOOR1)x ;(ii) a benzoguanamine compound of the formula C3N5(C6H5)(CH2OR)4-y (CH2NHCOOR1)y ;(iii) an oligomer of (i) or of (ii);and(iv) a mixture of at least two of any of (i), (ii) and (iii), wherein the R groups are, independently, hydrogen or alkyl from 1 to 12 carbon atoms, the Rl groups are, independently, alkyl of from 1 to 20 carbon atoms, x is in the range of from about 2 to about 6, and y is in the range of from about 2 to about 4.
  2. 2
    A triaminotriazine compound (i) as defined in Claim 1 wherein x is from about 2.8 to about 6, and wherein R is Cl-C8 alkyl and R1 is methyl, ethyl, n-propyl, butyl, i-propyl, n-octyl, 2-ethylhexyl, n-octadecyl, or a mixture of any of the foregoing.
  3. 3
    A benzoguanamine compound (ii) as defined in Claim 1 wherein x is from about 2.2 to about 4, and wherein R is Cl-C8 alkyl and Rl is methyl, ethyl, n-propyl, butyl, i-propyl, n-octyl, 2-ethylhexyl, n-octadecyl, or a mixture of any of the foregoing.
  4. 4
    An oligomer of a triaminotriazine compound (iii) (i) as defined in Claim 1 wherein R is Cl-C8 lower alkyl and R1 is methyl, ethyl, n propyl, butyl, i-propyl, n octyl, 2-ethylhexyl, n-octadecyl, or a mixture of any of the foregoing.
  5. 5
    A curable composition comprising:(a) an active hydrogen-containing material;(b) a triazine compound selected from (i) a triaminotriazine compound of the formula C3N6(CH20R)6-x (CH2NHCOOR1)x;(ii) a benzoguanamine compound of the formula C3N5(C6H5)(CH20R)4-y (CH2NHCOORl)y;(iii) an oligomer of (i) or of (ii);and(iv) a mixture of at least two of any of (i), (ii) and (iii), wherein the R groups are, independently, hydrogen or alkyl from 1 to 12 carbon atoms, the Rl groups are, independently, alkyl - of from 1 to 20 carbon atoms, x is in the range of from about 2 to about 6, and y is in the range of from about 2 to about 4;and(c) a cure catalyst.
  6. 6
    A curable composition as defined in Claim 5 wherein the active hydrogen-containing material is a polymeric material containing at least one class of reactive groups selected from carboxyl groups, alcoholic hydroxy groups, amide groups, amine groups or a mixture of any of such groups or a group convertible to any of such groups.
  7. 7
    A curable composition as defined in Claim 5 wherein the triazine compound is a triaminotriazine compound (i) wherein x is from about 2.8 to about 6, R is Cl-C8 alkyl and Rl is methyl, ethyl, n-propyl, butyl, i-propyl, n-octyl, 2-ethylhexyl, n-octadecyl, or a mixture of any of the foregoing.
  8. 8
    A curable composition as defined in Claim 5 wherein the cure catalyst comprises tetrabutyldiacetoxy stannoxane, dibutyltin dilaurate or dimethyltin dilaurate.
  9. 9
    A substrate protectively coated with a cured composition as defined in Claim 5.
  10. 10
    An article of manufacture comprising a cured composition as defined in Claim 5 and a filler.